{"id":"https://openalex.org/W2064530706","doi":"https://doi.org/10.1158/1078-0432.ccr-12-2832","title":"Hepatocyte Growth Factor Sensitizes Brain Tumors to c-MET Kinase Inhibition","display_name":"Hepatocyte Growth Factor Sensitizes Brain Tumors to c-MET Kinase Inhibition","publication_year":2013,"publication_date":"2013-02-05","ids":{"openalex":"https://openalex.org/W2064530706","doi":"https://doi.org/10.1158/1078-0432.ccr-12-2832","mag":"2064530706","pmid":"https://pubmed.ncbi.nlm.nih.gov/23386689","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3602223"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-12-2832","doi":"https://doi.org/10.1158/1078-0432.ccr-12-2832","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-12-2832","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/articles/PMC3602223","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100386105","display_name":"Ying Zhang","orcid":"https://orcid.org/0000-0002-2675-9213","observed_orcids":["https://orcid.org/0000-0002-2675-9213"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ying Zhang","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083425017","display_name":"Kaitlyn E. Farenholtz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaitlyn E. Farenholtz","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080914162","display_name":"Yanzhi Yang","orcid":"https://orcid.org/0000-0001-5128-7054","observed_orcids":["https://orcid.org/0000-0001-5128-7054"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yanzhi Yang","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012671751","display_name":"Fadila Guessous","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fadila Guessous","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002237814","display_name":"Charles G. diPierro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles G. diPierro","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006836320","display_name":"Valerie S. Calvert","orcid":"https://orcid.org/0000-0002-5075-7728","observed_orcids":["https://orcid.org/0000-0002-5075-7728"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valerie S. Calvert","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103832402","display_name":"Jianghong Deng","orcid":"https://orcid.org/0000-0002-3292-4676","observed_orcids":["https://orcid.org/0000-0002-3292-4676"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianghong Deng","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023905352","display_name":"David Schiff","orcid":"https://orcid.org/0000-0002-1896-2502","observed_orcids":["https://orcid.org/0000-0002-1896-2502","https://orcid.org/0000-0003-1561-9220"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Schiff","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102793291","display_name":"Wenjun Xin","orcid":"https://orcid.org/0000-0002-3172-1017","observed_orcids":["https://orcid.org/0000-0002-3172-1017"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenjun Xin","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066164452","display_name":"Jae K. Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jae K. Lee","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076042525","display_name":"Benjamin W. Purow","orcid":"https://orcid.org/0000-0001-7372-6062","observed_orcids":["https://orcid.org/0000-0001-7372-6062"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Purow","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074923974","display_name":"James G. Christensen","orcid":"https://orcid.org/0000-0003-1835-0335","observed_orcids":["https://orcid.org/0000-0003-1835-0335"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Christensen","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115076571","display_name":"Emanuel F. Petricoin","orcid":"https://orcid.org/0000-0001-8787-5990","observed_orcids":["https://orcid.org/0000-0001-8787-5990"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emanuel Petricoin","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","George Mason University, Fairfax","Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"George Mason University, Fairfax","institution_ids":["https://openalex.org/I162714631"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044442671","display_name":"Roger Abounader","orcid":"https://orcid.org/0000-0003-4075-9460","observed_orcids":["https://orcid.org/0000-0003-4075-9460"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Roger Abounader","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","Public Health Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Microbiology, Immunology and Cancer Biology, 2Neurology, and 3Pathology, and 4Cancer Center, University of Virginia, Charlottesville; 5Public Health Sciences; 6George Mason University, Fairfax; and 7Pfizer Global Research and Development, Richmond, Virginia","institution_ids":["https://openalex.org/I162714631","https://openalex.org/I51556381"]},{"raw_affiliation_string":"Public Health Sciences","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5044442671","https://openalex.org/A5100386105"],"corresponding_institution_ids":["https://openalex.org/I162714631","https://openalex.org/I180857899","https://openalex.org/I51556381"],"apc_list":null,"apc_paid":null,"fwci":2.3761,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.88885591,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"19","issue":"6","first_page":"1433","last_page":"1444"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7134000062942505,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7134000062942505,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.26589998602867126,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocyte-growth-factor","display_name":"hepatocyte growth factor","score":0.9549999833106995},{"id":"https://openalex.org/keywords/c-met","display_name":"c-Met","score":0.8140000104904175},{"id":"https://openalex.org/keywords/c-met-kinase-inhibitors","display_name":"c-Met inhibitor","score":0.8009999990463257},{"id":"https://openalex.org/keywords/brain-tumors","display_name":"brain tumors","score":0.8859999775886536},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/medulloblastoma","display_name":"medulloblastoma","score":1.0},{"id":"https://openalex.org/keywords/glioblastoma-stem-cells","display_name":"glioblastoma stem cells","score":0.9869999885559082},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6930000185966492},{"id":"https://openalex.org/keywords/egf-receptor","display_name":"EGF receptor","score":0.6259999871253967},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-inhibitors","display_name":"receptor tyrosine kinase inhibitors","score":0.9169999957084656},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.47699999809265137}],"concepts":[{"id":"https://openalex.org/C2776996007","wikidata":"https://www.wikidata.org/wiki/Q2399112","display_name":"Hepatocyte growth factor","level":3,"score":0.8535721898078918},{"id":"https://openalex.org/C2780467284","wikidata":"https://www.wikidata.org/wiki/Q5005897","display_name":"C-Met","level":4,"score":0.7231916785240173},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6339112520217896},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.6140096187591553},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5934670567512512},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.513827383518219},{"id":"https://openalex.org/C2780789225","wikidata":"https://www.wikidata.org/wiki/Q1333608","display_name":"Medulloblastoma","level":2,"score":0.485908180475235},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47837725281715393},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.45647650957107544},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43962612748146057},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.4111637473106384},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3693799376487732},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3458108901977539},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.34447553753852844},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30042901635169983},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2168809175491333},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1402551531791687},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09667691588401794},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017228","descriptor_name":"Hepatocyte Growth Factor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D017228","descriptor_name":"Hepatocyte Growth Factor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019859","descriptor_name":"Proto-Oncogene Proteins c-met","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019859","descriptor_name":"Proto-Oncogene Proteins c-met","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-12-2832","doi":"https://doi.org/10.1158/1078-0432.ccr-12-2832","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-12-2832","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:23386689","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23386689","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2934750","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3602223","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3602223","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3602223","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2934750","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3602223","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1539784606","display_name":"Molecular interactions and restoration strategies of PTEN and p53 in gliomas","funder_award_id":"R01CA134843","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1989192761","display_name":"Novel RTK Targeting Strategies in Glioblastoma","funder_award_id":"R01NS045209","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G9000901327","display_name":"University of Virginia Cancer Center Support Grant","funder_award_id":"P30CA044579","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1214944030","https://openalex.org/W1481003824","https://openalex.org/W1556788203","https://openalex.org/W1649526546","https://openalex.org/W1984041688","https://openalex.org/W1986159749","https://openalex.org/W1986179131","https://openalex.org/W1989401198","https://openalex.org/W1989848888","https://openalex.org/W1992301683","https://openalex.org/W1998971866","https://openalex.org/W2008345619","https://openalex.org/W2011138678","https://openalex.org/W2011717936","https://openalex.org/W2011883817","https://openalex.org/W2012219375","https://openalex.org/W2012498136","https://openalex.org/W2012792646","https://openalex.org/W2013678879","https://openalex.org/W2016146051","https://openalex.org/W2018671779","https://openalex.org/W2038056960","https://openalex.org/W2040483232","https://openalex.org/W2042919832","https://openalex.org/W2049808871","https://openalex.org/W2069421644","https://openalex.org/W2096844786","https://openalex.org/W2114383061","https://openalex.org/W2117293305","https://openalex.org/W2118593202","https://openalex.org/W2120018526","https://openalex.org/W2120729803","https://openalex.org/W2121769182","https://openalex.org/W2122686914","https://openalex.org/W2123326378","https://openalex.org/W2126890008","https://openalex.org/W2132763214","https://openalex.org/W2135873813","https://openalex.org/W2137390717","https://openalex.org/W2138896702","https://openalex.org/W2139668356","https://openalex.org/W2140334822","https://openalex.org/W2150037470","https://openalex.org/W2150291313","https://openalex.org/W2166927748","https://openalex.org/W2168805837","https://openalex.org/W2169820958","https://openalex.org/W2399220382","https://openalex.org/W2404856393","https://openalex.org/W4238115381","https://openalex.org/W6680753382","https://openalex.org/W6713321811"],"related_works":["https://openalex.org/W2034624764","https://openalex.org/W69147848","https://openalex.org/W2051339774","https://openalex.org/W2150291313","https://openalex.org/W1974959219","https://openalex.org/W2329224199","https://openalex.org/W1858612658","https://openalex.org/W2051469771","https://openalex.org/W1992031126","https://openalex.org/W2106688644"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,32],"receptor":[2,204],"tyrosine":[3],"kinase":[4,206],"(RTK)":[5],"c-MET":[6,27,48,77,147,162,192,224],"and":[7,16,21,50,69,84,90,101,131,153,166,178,226],"its":[8],"ligand":[9,228],"hepatocyte":[10],"growth":[11],"factor":[12],"(HGF)":[13],"are":[14],"deregulated":[15],"promote":[17],"malignancy":[18],"in":[19,59,79,102,129,132,164],"cancer":[20],"brain":[22,60],"tumors.":[23,61],"Consequently,":[24],"clinically":[25],"applicable":[26],"inhibitors":[28,49,78,128],"have":[29],"been":[30],"developed.":[31],"purpose":[33],"of":[34,82,126,144,176,191,214,217,240],"this":[35],"study":[36],"was":[37],"to":[38,47,51,76,114,146,201,223],"investigate":[39],"the":[40,66,124,127,150,188,212,237],"not-well-known":[41],"molecular":[42,67],"determinants":[43],"that":[44,73,137,160,173,219],"predict":[45],"responsiveness":[46],"explore":[52],"new":[53,120,233],"strategies":[54],"for":[55,122,235],"improving":[56,123,236],"inhibitor":[57],"efficacy":[58,125,239],"EXPERIMENTAL":[62],"DESIGN:":[63],"We":[64,117,135,194],"investigated":[65],"factors":[68,152],"pathway":[70,157],"activation":[71,158],"signatures":[72],"determine":[74],"sensitivity":[75],"a":[80,141,196,215,231],"panel":[81],"glioblastoma":[83,87],"medulloblastoma":[85],"cells,":[86,89],"stem":[88],"established":[91],"cell":[92],"line-derived":[93],"xenografts":[94],"using":[95],"functional":[96],"assays,":[97],"reverse":[98],"protein":[99],"microarrays,":[100],"vivo":[103],"tumor":[104],"volume":[105],"measurements,":[106],"but":[107,184],"validation":[108],"with":[109,180],"animal":[110],"survival":[111],"analyses":[112],"remains":[113],"be":[115,221],"done.":[116],"also":[118,171],"explored":[119],"approaches":[121],"vitro":[130],"vivo.":[133],"RESULTS:":[134],"found":[136,172],"HGF":[138,182],"coexpression":[139],"is":[140],"key":[142],"predictor":[143],"response":[145],"inhibition":[148,163,225],"among":[149],"examined":[151],"identified":[154],"an":[155,202],"ERK/JAK/p53":[156],"signature":[159],"differentiates":[161],"responsive":[165,222],"nonresponsive":[167],"cells.":[168],"Surprisingly,":[169],"we":[170],"short":[174],"pretreatment":[175,229],"cells":[177],"tumors":[179],"exogenous":[181],"moderately":[183],"statistically":[185],"significantly":[186],"enhanced":[187],"antitumor":[189],"effects":[190],"inhibition.":[193],"observed":[195],"similar":[197],"ligand-induced":[198],"sensitization":[199],"effect":[200],"EGF":[203],"small-molecule":[205],"inhibitor.":[207],"CONCLUSIONS:":[208],"These":[209],"findings":[210],"allow":[211],"identification":[213],"subset":[216],"patients":[218],"will":[220],"propose":[227],"as":[230],"potential":[232],"strategy":[234],"anticancer":[238],"RTK":[241],"inhibitors.":[242]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}